# H7N9 Boost in Healthy Adults

> **NCT02586792** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 27 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Monovalent influenza A/H7N9 virus vaccine

## Key facts

- **NCT ID:** NCT02586792
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-12
- **Primary completion:** 2016-12-29
- **Final completion:** 2016-12-29
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02586792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02586792, "H7N9 Boost in Healthy Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02586792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*